ELAN - Elanco Animal Health Inc
Close
15.47
0.180 1.164%
Share volume: 3,683,659
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$15.29
0.18
1.18%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-08 | 2023-03-01 | 2023-05-09 | 2023-08-07 | 2023-11-07 | 2024-02-26 | 2024-05-08 | |
| Assets | |||||||||
| Total Assets | 15.601 B | 14.948 B | 15.491 B | 15.769 B | 15.796 B | 14.344 B | 14.362 B | 14.019 B | |
| Current Assets | 3.307 B | 3.154 B | 3.279 B | 3.548 B | 3.652 B | 3.565 B | 3.407 B | 4.050 B | |
| Inventories | 1.334 B | 1.340 B | 1.538 B | 1.596 B | 1.690 B | 1.690 B | 1.735 B | 1.638 B | |
| Other Current Assets | 338.000 M | 326.000 M | 394.000 M | 370.000 M | 370.000 M | 371.000 M | 310.000 M | 338.000 M | |
| Short Term Investments | 338.000 M | 326.000 M | 394.000 M | 370.000 M | 370.000 M | 371.000 M | 310.000 M | 338.000 M | |
| Total Receivables | 1.128 B | 1.028 B | 1.002 B | 1.264 B | 1.225 B | 1.135 B | 1.010 B | 1.078 B | |
| Current Cash | 507.000 M | 460.000 M | 345.000 M | 318.000 M | 367.000 M | 369.000 M | 352.000 M | 345.000 M | |
| Total Non-current Assets | 12.294 B | 11.794 B | 12.212 B | 12.221 B | 12.144 B | 10.779 B | 10.955 B | 9.969 B | |
| Property Plant Equipment | 961.000 M | 936.000 M | 999.000 M | 1.000 B | 1.007 B | 992.000 M | 1.026 B | 949.000 M | |
| Other Assets | 376.000 M | 376.000 M | 378.000 M | 369.000 M | 419.000 M | 410.000 M | 341.000 M | 346.000 M | |
| Intangible Assets | 5.059 B | 4.766 B | 4.842 B | 4.791 B | 4.678 B | 4.475 B | 4.494 B | 4.196 B | |
| Goodwill | 5.898 B | 5.716 B | 5.993 B | 6.061 B | 6.040 B | 4.902 B | 5.094 B | 4.478 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 15.601 B | 14.948 B | 15.491 B | 15.769 B | 15.796 B | 14.344 B | 14.362 B | 14.019 B | |
| Total liabilities | 8.461 B | 8.203 B | 8.202 B | 8.289 B | 8.376 B | 8.210 B | 8.139 B | 7.963 B | |
| Total current liabilities | 1.338 B | 1.613 B | 1.702 B | 1.578 B | 1.284 B | 1.265 B | 1.241 B | 1.232 B | |
| Accounts Payable | 386.000 M | 350.000 M | 390.000 M | 381.000 M | 354.000 M | 296.000 M | 270.000 M | 302.000 M | |
| Other liabilities | 496.000 M | 465.000 M | 390.000 M | 409.000 M | 411.000 M | 432.000 M | 595.000 M | 474.000 M | |
| Current long term debt | 56.000 M | 394.000 M | 388.000 M | 381.000 M | 39.000 M | 39.000 M | 38.000 M | 38.000 M | |
| Long term debt | 6.007 B | 5.507 B | 5.448 B | 5.639 B | 6.023 B | 5.870 B | 5.736 B | 5.727 B | |
| Other liabilities | 496.000 M | 465.000 M | 390.000 M | 409.000 M | 411.000 M | 432.000 M | 595.000 M | 474.000 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 7.140 B | 6.745 B | 7.289 B | 7.480 B | 7.420 B | 6.134 B | 6.223 B | 6.056 B | |
| Common stock | 488.400 M | 488.400 M | 488.400 M | 491.100 M | 492.600 M | 492.700 M | 492.800 M | 493.200 M | |
| Retained earnings | -923.000 M | -972.000 M | -1.057 B | -954.000 M | -1.051 B | -2.147 B | -2.288 B | -2.256 B |